Vasopressin Enrolling by Invitation Phase 4 Trials for Acute Kidney Injury (AKI) / End-stage Liver Disease (ESLD) / Cirrhosis of the Liver / Complication of Transplanted Liver Prevention

Indications	Status	Purpose	Phase
DBCOND0068886 (Acute Kidney Injury (AKI)) DBCOND0081406 (End-stage Liver Disease (ESLD)) DBCOND0056665 (Cirrhosis of the Liver) DBCOND0043214 (Complication of Transplanted Liver)	Enrolling by Invitation	Prevention	4

clinicaltrials.gov Identifier	Title	Drugs
NCT04592744	Angiotensin 2 for AKI After OLT	Angiotensin II (DB11842) Epinephrine (DB00668) Norepinephrine (DB00368) Vasopressin (DB00067)